相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-Resolution Genetic Mapping Using the Mouse Diversity Outbred Population
Karen L. Svenson et al.
GENETICS (2012)
Spontaneous Tumor Incidence in rasH2 Mice: Review of Internal Data and Published Literature
Prashant R. Nambiar et al.
TOXICOLOGIC PATHOLOGY (2012)
Establishing a Laboratory Animal Model From a Transgenic Animal: RasH2 Mice as a Model for Carcinogenicity Studies in Regulatory Science
K. Urano et al.
VETERINARY PATHOLOGY (2012)
Genetic analysis of complex traits in the emerging Collaborative Cross
David L. Aylor et al.
GENOME RESEARCH (2011)
The Collaborative Cross: A Recombinant Inbred Mouse Population for the Systems Genetic Era
David W. Threadgill et al.
ILAR JOURNAL (2011)
A continuum model for tumour suppression
Alice H. Berger et al.
NATURE (2011)
Transgenic Animal Models in Toxicology: Historical Perspectives and Future Outlook
Darrell R. Boverhof et al.
TOXICOLOGICAL SCIENCES (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
Genetically modified mice-successes and failures of a widely used technology
Hayo Castrop
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Cancer Risk Assessment Approaches at the FDA/CDER: Is the Era of the 2-Year Bioassay Drawing to a Close?
David Jacobson-Kram
TOXICOLOGIC PATHOLOGY (2010)
Panel Discussion: Alternative Mouse Models for Carcinogenicity Assessment
John E. French et al.
TOXICOLOGIC PATHOLOGY (2010)
An Industry Perspective on the Utility of Short-Term Carcinogenicity Testing in Transgenic Mice in Pharmaceutical Development
Richard D. Storer et al.
TOXICOLOGIC PATHOLOGY (2010)
The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies-Implications for REACH
Monique Y. Wells et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Benzene-Induced Hematopoietic Neoplasms Including Myeloid Leukemia in Trp53-Deficient C57BL/6 and C3H/He Mice
Yasushi Kawasaki et al.
TOXICOLOGICAL SCIENCES (2009)
20 years studying p53 functions in genetically engineered mice
Lawrence A. Donehower et al.
NATURE REVIEWS CANCER (2009)
The expanding universe of p53 targets
Daniel Menendez et al.
NATURE REVIEWS CANCER (2009)
Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice
Antonella Sgura et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2008)
The Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems genetics
Elissa J. Chesler et al.
MAMMALIAN GENOME (2008)
Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53-haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC
Vasily N. Dobrovolsky et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2007)
Mouse skin models for carcinogenic hazard identification: Utilities and challenges
Dave Lynch et al.
TOXICOLOGIC PATHOLOGY (2007)
Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review
MC Humble et al.
ONCOGENE (2005)
Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53
M Jaworski et al.
CARCINOGENESIS (2005)
High susceptibility of human c-Ha-ras protooncogene transgenic rats to carcinogenesis: A cancer-prone animal model
H Tsuda et al.
CANCER SCIENCE (2005)
Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains
M Ozaki et al.
TOXICOLOGIC PATHOLOGY (2005)
Exposure of Tg.AC transgenic mice to benzene suppresses hematopoietic progenitor cells and alters gene expression in critical signaling pathways
VC Nwosu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Gene expression profiling of p53+/- knockout and wild-type mice following diethylstilbestrol administration
MN Salleh et al.
IUBMB LIFE (2004)
The Collaborative Cross, a community resource for the genetic analysis of complex traits
G Churchill et al.
NATURE GENETICS (2004)
The role of transgenic mouse models in carcinogen identification
JB Pritchard et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Role of gene knockout and transgenic mice in the study of xenobiotic metabolism
FJ Gonzalez
DRUG METABOLISM REVIEWS (2003)
Environmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis
D Medina et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2002)
Alternative models for carcinogenicity testing
SM Cohen et al.
TOXICOLOGICAL SCIENCES (2001)
DNA repair-deficient Xpa and Xpa/p53+/-knock-out mice:: Nature of the models
H van Steeg et al.
TOXICOLOGIC PATHOLOGY (2001)
Is p53 haploinsufficient for tumor suppression?: Implications for the p53+/-mouse model in carcinogenicity testing
S Venkatachalam et al.
TOXICOLOGIC PATHOLOGY (2001)
The Tg.AC (v-Ha-ras) Transgenic mouse: Nature of the model
RW Tennant et al.
TOXICOLOGIC PATHOLOGY (2001)
Dermal carcinogenicity in transgenic mice: Effect of vehicle on responsiveness of hemizygous Tg.AC mice to phorbol 12-myristate 13-acetate (TPA)
RE Stoll et al.
TOXICOLOGIC PATHOLOGY (2001)
p53+/- Hemizygous knockout mouse:: Overview of available data
RD Storer et al.
TOXICOLOGIC PATHOLOGY (2001)
Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment
DE Robinson et al.
TOXICOLOGIC PATHOLOGY (2001)
A perspective on current and future uses of alternative models for carcinogenicity testing
JI Goodman
TOXICOLOGIC PATHOLOGY (2001)
The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens
J French et al.
TOXICOLOGIC PATHOLOGY (2001)
Mechanisms of hormonal carcinogenesis in the p53+/--hemizygous knockout mouse:: Studies with diethylstilbestrol
PL Carmichael et al.
TOXICOLOGIC PATHOLOGY (2001)
Comparative xenobiotic metabolism between Tg.AC and p53+/- genetically altered mice and their respective wild types
JM Sanders et al.
TOXICOLOGICAL SCIENCES (2001)
The use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesis
FJ Gonzalez
TOXICOLOGY LETTERS (2001)
New models for assessing carcinogenesis: An ongoing process
RC Sills et al.
TOXICOLOGY LETTERS (2001)
Induction and time-dependent accumulation of micronuclei in peripheral blood of transgenic p53± mice, Tg.AC (v-Ha-ras) and parental wild-type (C57BL/6 and FVB/N) mice exposed to benzene by inhalation
LN Healy et al.
MUTAGENESIS (2001)
Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool
JL Luo et al.
ONCOGENE (2001)
Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice
JE Hulla et al.
CARCINOGENESIS (2001)
Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen- and tissue-dependent
JE French et al.
CARCINOGENESIS (2001)
Mammary tumor induction and premature ovarian failure in Apc(Min) mice are not enhanced by Brca2 deficiency
LM Bennett et al.
TOXICOLOGIC PATHOLOGY (2001)
Statistical analysis of skin tumor data from Tg.AC mouse bioassays
DB Dunson et al.
TOXICOLOGICAL SCIENCES (2000)
Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model
RR Maronpot et al.
TOXICOLOGY (2000)
Current status and use of short/medium-term models for assessment of carcinogenicity of human pharmaceuticals: regulatory perspectives
JW van der Laan
TOXICOLOGY LETTERS (2000)
Use of transgenic animals for carcinogenicity testing: Considerations and implications for risk assessment
D Gulezian et al.
TOXICOLOGIC PATHOLOGY (2000)
Manipulating the germline: its impact on the study of carcinogenesis
AR Clarke
CARCINOGENESIS (2000)
Responses of transgenic mouse lines p53+/- and Tg•AC to agents tested in conventional carcinogenicity bioassays
JW Spalding et al.
TOXICOLOGICAL SCIENCES (2000)
分享论文
